CelaneseFRA:DG3 +1.14%73 EBITDA Margin % is 20.24% as of Mar. 2026, which is 17% below its 10-year median of 24.26. GuruFocus rates FRA:DG3 with a GF Score™ of 73/100 and a GF Value™ of €59.88 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 1,585 Chemicals companies, Celanese ranks worse than 72.56% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Celanese's EBITDA for the
three
months ended in Mar. 2026 was €409 Mil. Celanese's Revenue for the
three
months ended in Mar. 2026 was €2,022 Mil. Therefore, Celanese's EBITDA margin for the quarter that ended in Mar. 2026 was 20.24%.
Celanese (FRA:DG3) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Celanese EBITDA Margin % Related Terms
Celanese EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Celanese's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:DG3 vs OLN, HUN, REX: EBITDA Margin % Comparison
For the Chemicals subindustry, Celanese's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Celanese EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Celanese's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Celanese's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Celanese (FRA:DG3) has a EBITDA Margin % of 20.24% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Celanese and its competitors. This is 17% below median its historical median of 24.26. Over the past decade, Celanese's EBITDA Margin % has ranged from 2.80 to 48.03. According to the industry distribution chart, Celanese ranks #1150 out of 1585 companies in the Chemicals industry, placing it in the top 72.6%.
Is Celanese's EBITDA Margin % too high?
Celanese's current EBITDA Margin % of 20.24% is 17% below median its 10-year median of 24.26. Over the past 10 years, this metric has ranged from a low of 2.80 to a high of 48.03. The Chemicals industry median EBITDA Margin % is 9.63. Celanese's value of 20.24% is 110.2% above this industry median. Based on the distribution chart, Celanese ranks #1150 out of 1585 companies in the Chemicals industry, which is below the industry midpoint. Overall, Celanese has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Celanese's EBITDA Margin % compare to OLN and HUN?
According to the Chemicals industry distribution chart, Celanese ranks #1150 out of 1585 companies for EBITDA Margin %. This places Celanese in the lower half of its industry. The industry median EBITDA Margin % is 9.63. Celanese's value of 20.24% is 110.2% above this benchmark. Historically, Celanese's own EBITDA Margin % has ranged from 2.80 to 48.03 over the past decade. While the company's 10-year median is 24.26 vs. the industry median of 9.63, Celanese has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Celanese's current EBITDA Margin % of 20.24% is 110.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Celanese and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Celanese's current EBITDA Margin % is 20.24%, which is 17% below median its own 10-year median of 24.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Celanese stock overvalued right now?
Based on GuruFocus' analysis, Celanese (FRA:DG3) is currently considered Modestly Undervalued. The stock's GF Value™ is €59.88, compared to a current price of €42.62 — trading 28.8% below its estimated fair value. The current EBITDA Margin % is 20.24%, which is 17% below median its 10-year median of 24.26 and 110.2% above the Chemicals industry median of 9.63. Celanese's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Celanese (FRA:DG3), the current EBITDA Margin % is 20.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Celanese (FRA:DG3) Overvalued in 2026?
Based on GuruFocus' analysis, Celanese stock appears to be undervalued.
The current stock price of €42.62 is trading 28.8% below its estimated GF Value™ of €59.88.
GuruFocus considers Celanese to be Modestly Undervalued.
Key valuation signals for FRA:DG3:
EBITDA Margin %: 20.24% (17% below median its 10-year median of 24.26)
GF Value™: €59.88 vs. price of €42.62 (28.8% below fair value)
Industry Position: 110.2% above the Chemicals median (#1150 of 1585)
No single metric tells the full story. See the FRA:DG3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.
73GF Score
Get the complete analysis for FRA:DG3
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DG3 has been successfully added to your 
